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Background: Prefrontal and temporo-parietal repetitive transcranial magnetic stimu-
lation (rTMS) in patients suffering from chronic tinnitus have shown significant but only 
moderate effectiveness with high interindividual variability in treatment response. This 
open-label pilot study was designed to examine the general feasibility of an individualized 
fronto-temporal rTMS protocol and to explore what criteria are needed for a more 
detailed evaluation in randomized clinical studies.
Methods: During the first session of a 2-week rTMS protocol, we applied different 
rTMS protocols to the left and right temporo-parietal and dorsolateral prefrontal cortex 
(DLPFC) in 25 tinnitus patients. Short trains of 1, 5, 10, and 20  Hz and continuous 
theta burst stimulation were applied, and patients were asked for immediate tinnitus 
reductions after each train. If a patient reported such improvements, rTMS treatment 
was applied over nine sessions with a combined protocol consisting of the most effec-
tive frontal and the most effective temporo-parietal stimulation protocol. Those patients 
who did not improve after the test session were treated with a standard prefrontal plus 
temporo-parietal protocol (20 Hz over left DLPFC + 1 Hz over temporo-parietal cortex).
results: Almost half of the patients (12 of 25) reported immediate tinnitus reductions 
during the test session. In this group, the mean pre- to post-treatment amelioration in the 
tinnitus questionnaire was higher (medium to high effect sizes) in contrast to the patients 
who did not respond to the test session. Treatment outcome remained stable over a 
follow-up period of 10 weeks.
Discussion: Individualized rTMS was shown to be feasible and effective in chronic 
tinnitus. The results obtained from this study provide tentative evidence in support of 
an individualized rTMS treatment approach and might provide a basis for a “tailored” 
application of rTMS in tinnitus and other neuropsychiatric disorders.
Keywords: chronic tinnitus, repetitive transcranial magnetic stimulation, individualized repetitive transcranial 
magnetic stimulation, neuromodulation, neurostimulation
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inTrODUcTiOn
chronic Tinnitus
Subjective tinnitus is characterized by the perception of sound in 
the absence of a corresponding sound source (1). Approximately 
1% of the general population report severe tinnitus-related 
impairment of daily living (2) and seek medical help (3). In con-
trast to auditory hallucinations that occur in mental disorders 
and mainly refer to the perception of voices, tinnitus sensations 
are usually of an unformed acoustic nature such as buzzing, 
hissing, or ringing (4). Severe tinnitus is frequently associated 
with depressive symptoms (5), anxiety (6, 7), and insomnia (8), 
and its socioeconomic relevance is illustrated by the dramatically 
increased risk for disability pension among tinnitus patients 
(9). The available evidence-based treatments for tinnitus have 
only small effect sizes (4, 10, 11), indicating the urgent need for 
the development and optimization of innovative therapeutic 
attempts.
neurobiological Underpinnings of chronic 
Tinnitus
Formerly considered as an otological disorder, tinnitus treat-
ment approaches exclusively targeting the cochlea have led to 
discouraging results in most cases (12). However, during the 
last years, advances in neuroimaging and the development of 
animal models have shifted the perspective toward the neuronal 
pathologies underlying the different forms of tinnitus (13). 
There is convincing evidence emerging from functional imag-
ing (14) and neurophysiological studies (15, 16) that tinnitus is 
not only related to abnormal functioning of the central auditory 
system (1) but also related to abnormal activity of non-auditory 
brain regions (17, 18) and abnormal functional connectivity 
between these regions (19–22). Imaging studies have shown 
that coactivation of prefrontal areas might especially be related 
to the affective components of tinnitus (5, 22, 23). It has been 
further proposed that limbic and paralimbic structures may 
form a fronto-thalamic gating system for tinnitus perception 
(24). According to this model, increased neuronal activity arises 
in the auditory pathways as a consequence of deafferentation 
due to hearing loss. If altered activity in auditory networks is 
connected to activation of motivational and emotional brain 
networks, the inhibitory influence from this fronto-thalamic 
gating system is downregulated, thus allowing the tinnitus 
signal to propagate to the auditory cortices, which finally leads 
to conscious perception. This is in line with electrophysiologi-
cal studies that demonstrated the relevance of dysfunctional 
top–down inhibitory mechanisms originating in the prefrontal 
lobe for tinnitus generation (22, 25, 26). Therefore, two potential 
targets for brain stimulation can be identified: first, the frontal 
cortex with the aim to enhance the activity of the fronto-striato-
thalamic gating mechanism, and second, the temporal cortex 
with the aim to reduce cortical activity in the auditory cortex. In 
line with this notion, tinnitus reduction has been demonstrated 
after repetitive transcranial magnetic stimulation (rTMS), tDCS, 
and direct cortical stimulation of both frontal and temporal 
cortices (27, 28).
rTMs in chronic Tinnitus
On the basis of initial findings of abnormal functioning of central 
auditory structures (1), rTMS of the temporal and temporo-
parietal cortex has been proposed as a potential treatment for 
chronic tinnitus (29). Several clinical studies showed a sham-
controlled reduction of tinnitus severity after repeated 1 Hz rTMS 
applied to the left temporal cortex (30–34), but some studies were 
also negative (35, 36). In a meta-analysis, treatment effects were 
shown to be significant, but effect sizes were moderate at best 
and interindividual variability in treatment response is high (37).
The Status Quo
As mentioned above, rTMS treatment results in chronic tinnitus 
are currently burdened by only moderate improvement (38) and 
high interindividual variability indicating the need for optimi-
zation strategies. No demographic or clinical criteria could be 
identified as a predictor for rTMS treatment response in large 
samples of patients with chronic tinnitus (39). Several studies 
reported transient tinnitus suppression after a single session of 
rTMS (40). When the effects of different rTMS protocols over 
the temporal cortex were compared, it has been shown that the 
protocol with the best tinnitus suppressing effect differed from 
patient to patient (41). However, the individually best proto-
cols induced similar changes of oscillatory brain activity (42). 
Although single rTMS sessions reduced tinnitus only transiently 
for seconds to minutes, repeated daily rTMS stimulation resulted 
in longer lasting tinnitus reduction up to several months (30, 43, 
44) in some patients. Most studies investigating repeated sessions 
of rTMS used low-frequency rTMS with 1 Hz, even though two 
studies comparing the effects of 1 Hz rTMS with those of 10 and 
25 Hz revealed similar treatment effects for high-frequency rTMS 
(45, 46).
In light of these data, the question arises whether a test session, 
in which the immediate effects of different TMS protocols are 
evaluated, may be a feasible and useful approach for selecting the 
rTMS protocol for repeated rTMS sessions. To our knowledge, 
this question has not yet been addressed by any study, even if the 
sham-controlled response to single rTMS sessions has been used 
as a selection criterion for surgical implantation with epidural 
electrodes (47).
Both auditory and non-auditory brain regions are involved in 
tinnitus (48, 49), and combined frontal and temporal stimulation 
protocols exerted best effects in previous studies (22, 50, 51). 
Thus, the aim of the present study was to investigate the feasibility 
of an rTMS treatment approach that is (i) individualized based 
on the effects of single test sessions and that (ii) comprises both 
prefrontal and temporo-parietal cortices.
MaTerials anD MeThODs
study Design and conduct
The study was conducted following a two-armed pilot study 
design. As a first step, an initial rTMS testing session was con-
ducted in which 1, 5, 10, and 20 Hz; continuous theta burst rTMS; 
and sham were applied to (i) the left dorsolateral prefrontal cortex 
(DLPFC), (ii) the right DLPFC, (iii) the left temporo-parietal 
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junction area, and (iv) the right temporo-parietal junction area. 
The number of applied stimuli during the rTMS testing session on 
day 1 was 200 stimuli for each stimulation frequency and location 
(exception: 50 stimuli at 1 Hz frequency), resulting in a total of up 
to 4,200 stimuli. After the application of each protocol, patients 
were asked whether they had experienced a change in their tin-
nitus and were asked to rate the changes on a percentage level 
regarding to loudness. Patients wore insert earplugs during the 
testing session and were instructed to report immediate tinnitus 
changes in form of percentage values. The most effective protocol 
of each of the four stimulation locations was (i) repeated to assure 
retest validity and (ii) controlled by sham stimulation (applying 
the same paradigm with a tilted coil angle of 90° with one wing of 
the figure-of-eight coil on the head and magnetic field main direc-
tion, thus paralleling the scalp surface). Thus, sham conditions 
were different for each stimulation site and patient during the 
testing phase. For patients reporting the same tinnitus reduction 
for different stimulation protocols for the left and right frontal or 
for the left and right temporo-parietal stimulation sites, equally 
effective protocols were repeated and contrasted directly. Patients 
reporting immediate tinnitus modulation during the testing ses-
sion on day 1 (Monday) were consecutively treated by application 
of 9 further daily (only working days) combined stimulation 
sessions consisting of the most effective prefrontal stimulation 
protocol (2,000 stimuli) at the left or right hemisphere followed 
by the most effective temporo-parietal stimulation protocol (left 
or right, 2,000 stimuli/session). Patients who did not experience 
immediate tinnitus modulation during the testing session on day 
1 were treated by a “standard” combined treatment consisting of 
2,000 stimuli of 20 Hz rTMS delivered to the left DLPFC followed 
by 2,000 stimuli of 1 Hz rTMS of the left temporo-parietal junc-
tion area (n = 3) or a “triple” paradigm consisting of 2,000 stimuli 
of 20 Hz rTMS of the left DLPFC followed by rTMS (1,000 stimuli 
left, 1,000 stimuli right) of the bilateral temporo-parietal junction 
area (n = 9) (52). Due to ethical reasons, we switched treatment 
for the standard group as it turned out during the course of the 
present study that the triple stimulation is more effective than 
the former standard treatment (53). The treatment sessions fol-
lowing the testing session consisted of a total of 4,000 stimuli/
day for both the individualized and the standard group and were 
conducted on nine subsequent working days. Follow-up-visits 
were conducted 2 and 10 weeks after the end of the stimulation 
period (=week 4 and week 12 visit, respectively).
Stimulation was performed with a 70-mm figure-of-8 (=but-
terfly) coil (Cool-B65, Magventure A/S, Denmark) in 40 trains 
with 50 stimuli and an intertrain interval of 25 s (exception: 1 Hz 
stimulation was administered in one train). The coil was powered 
by a MagPro ×100 stimulator (Magventure A/S, Denmark). 
Stimulation was performed at 110% resting motor threshold 
(RMT) but not higher than 60% maximum stimulator output. 
RMT was defined as the lowest intensity sufficient to produce 
left abductor digiti minimi muscle activation (magnetic evoked 
potentials >50 μV) with a single pulse delivered to the motor cor-
tex in at least 5 of 10 trials and was determined before the testing 
session on day 1. For treatment of the left DLPFC, the conven-
tional butterfly coil was positioned 6 cm anterior of the left motor 
hotspot in a sagittal direction with the handle pointing backward 
in a 45° angle toward the midline (28). Temporo-parietal cortex 
localization was conducted following a protocol suggested by 
Khedr et al. (46) positioning the coil between the temporal (T3/
T4-electrode location) and parietal (P3/P4-location) (54) accord-
ing the 10–20 EEG-positioning system (55). Coil positioning was 
tangential to the scalp with the handle pointing upward.
All participants gave written informed consent after a com-
prehensive explanation of the study procedures that data were 
gathered and analyzed for the Tinnitus Research Initiative data-
base (56), which was approved by the Ethics Committee of the 
University Hospital of Regensburg (Germany, reference number 
08/046). All study procedures were carried out in accordance 
with the approved guidelines.
Patient enrollment
Inclusion criterion was subjective tinnitus with duration of more 
than 6  months. Exclusion criteria comprised objective tinnitus 
(with a treatable cause), ongoing other tinnitus treatments during 
or 3 months before study enrollment, the presence of clinically 
relevant psychiatric comorbidities or unstable medical condi-
tions, history or evidence of significant brain malformation or 
neoplasm, history of head injuries, cerebral vascular events, 
the presence of irremovable metal objects in and around the 
body, pregnancy, alcohol abuse or intake of illicit substances, 
and history of prior TMS treatment. Patients were recruited for 
participation in the study after presentation in the outpatient 
clinic of the Interdisciplinary Tinnitus Centre at the University 
of Regensburg, Regensburg, Germany. The study was conducted 
between November 2011 and June 2012.
Outcome Measures and Data Presentation
The outcome parameters were change in tinnitus distress and 
loudness measured with the tinnitus questionnaire (TQ; range 
0–84) (57) and a numeric rating scale (range 0–10), respectively. 
We present change from baseline to the week 2 visit to measure 
immediate treatment effects and also from pretreatment to post-
treatment defined as a mean value of the screening and baseline 
visits (pretreatment) and of the week 2, 4, and 12 visits (post-
treatment). In addition, we demonstrate the number of treatment 
responders defined as a minimal reduction of 5 points in the TQ 
(58). Further objectives were the assessment of adverse events 
and safety information at all visits. Data were assessed accord-
ing to international standards (59) and registered in a tinnitus 
database following ICH-GCP regulations (60, 61). We contrasted 
the group of patients who reported changes in tinnitus after a 
single session with the group of patients with no response.
All data are displayed as mean ± SD if not otherwise labeled. In 
case of missing data, the last observation was carried forward, and 
participants who did not complete rTMS treatment (dropouts) 
were excluded from analysis (n = 1). Due to the pilot character 
of the study, we focus on the feasibility and identification of 
modifications for future studies (62, 63). For this purpose, we 
report raw data and basic statistical tests for rough estimation 
of the efficacy of the tested treatments. All statistical tests were 
conducted two tailed, unadjusted for multiple comparisons, and a 
value of p < 0.05 was assumed as statistically significant. For group 
comparisons, we calculated Student’s t-tests for independent 
TaBle 1 | individual data for treatment with individualized repetitive transcranial magnetic stimulation (rTMs) and average group data for individualized 
and standard rTMs (each subject was stimulated with 4,000 pulses per day).
subject 
order
Kind of prefrontal 
stimulation
single-
session 
tinnitus 
reductiona
Kind of temporo-
parietal stimulation
single-
session 
tinnitus 
reductiona
resting motor 
threshold (rMT); 
stimulation 
intensity 
(stimulator 
output)b
change 
in tinnitus 
questionnaire 
(TQ) total score 
from baseline to 
week 2 visitd
change in TQ 
total score from 
pretreatment to 
posttreatmentc,d
Individualized 
treatment 
(single subject 
data)
1 Right continuous theta 
burst stimulation (cTBS)
70% Right 5 Hz 50% 42%; 46% 24 (−) 20.33 (−)
3 Right 10 Hz “Better” Left cTBS “Better” 34%; 37% 7 (−) 2.50 (+)
5 Left cTBS 40% Left 10 Hz 40% 43%; 47% 0 (+) 1.17 (+)
7 Left 20 Hz 50% Left 5 Hz 40% 46%; 51% 11 (−) 15.17 (−)
9 Left 5 Hz 20% Right cTBS 10% 37%; 41% 11 (−) 3.17 (+)
10 Left 20 Hz 2% Right 10 Hz 2% 33%; 36% −3 (+) −8.33 (+)
13 Left 20 Hz “Not sure” Left 20 Hz “Good” 50%; 55% 9 (−) 9.33 (−)
16 Right 20 Hz 30% Left 5 Hz 100% 57%; 60% −9 (+) 20.83 (−)
17 Left 5 Hz “Shortly 
better”
Right cTBS “Shortly off” 30%; 33% 20 (−) 5.67 (−)
18 Left cTBS 10% Left cTBS 10% 38%; 42% 3 (+) 9.83 (−)
23 Left 20 Hz 10% Right 20 Hz 10% 52%; 57% 10 (−) 8.33 (−)
24 Left 20 Hz 3% Left 10 Hz 4% 42%; 46% 3 (+) 5.33 (−)
Individualized 
treatment 
(mean ± SD)
n.a. 9/12 left; 5 Hz (n = 2), 
10 Hz (n = 1), 20 Hz 
(n = 6),cTBS (n = 3)
n.a. 7/12 left; 5 Hz (n = 3), 
10 Hz (n = 3), 20 Hz 
(n = 2), cTBS (n = 4)
n.a. 42 ± 8; 46 ± 9 7.17 ± 9.24  
(58% responder)
8.57 ± 8.92  
(67% responder)
Standard 
protocol 
(mean ± SD)
n.a. Left 20 Hz n.a. Left and/or right 1 Hz n.a. 43 ± 17; 43 ± 9 3.42 ± 7.04  
(42% responder)
1.46 ± 8.48  
(42% responder)
aNumbers indicate the percent of tinnitus reduction after a single-session stimulation; verbal statements are indicated by quotation marks.
bStimulation intensity was 110% of RMT; for safety reasons, 60% was the upper limit for stimulation intensity; RMT and stimulation intensity were comparable in the standard 
protocol group as two subjects had thresholds highly above 60%.
cVisits after treatment (week 2 + week 4 + final visit) minus visits before treatment (screening + baseline).
dResponder information in brackets (+ = yes, − = no).
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measures. Effect sizes are reported according to G*Power 3.1.2 
(64). Statistical data analysis was performed using IBM SPSS 
Statistics for Windows, version 22.0 (released 2013; IBM Corp., 
Armonk, NY, USA).
resUlTs
Feasibility
Twenty-five patients were recruited for participation in the study. 
One participant aborted the treatment after the first day due to 
headache after finishing the testing session on day 1 (without 
reporting immediate effects). Exactly 50% of the 24 remaining 
patients (n =  12) reported immediate modulation of their tin-
nitus percept during day 1 testing procedures and were therefore 
allocated to the individualized treatment arm receiving combined 
rTMS of prefrontal and temporo-parietal cortical areas for 
another 9 consecutive working days. Nine of the 12 patients who 
perceived a tinnitus change after TMS were able to indicate the 
change in a percentage value (ranging between 3 and 70%). The 
other three patients provided only vague estimations like “better” 
(see Table 1). Two patients experiencing the most pronounced 
improvement after active rTMS reported similar improvement 
after sham TMS during the testing session. No other patient 
reported tinnitus improvement after sham TMS. Also, these 
patients were assigned to the individualized arm (subject number 
1 and 7 in Table 1). Three patients in each of the study groups 
were under a psychotropic medication (individualized group: 1× 
citalopram 40 mg/day, 1× venlafaxine 225 mg/day, 1× opipramol 
100 mg/day; control group: 1× citalopram 40 mg/day +  trimi-
pramine 40  mg/day, 1× agomelatine 25  mg/day, 1× opipramol 
100 mg/day).
Concerning the other 12 patients without immediate tinnitus 
changes during the testing rTMS session, 3 were treated with 
the “standard double protocol” consisting of 2,000 stimuli to the 
left DLPFC at 20 Hz frequency followed by 2,000 stimuli to the 
left temporo-parietal cortex at 1 Hz and 9 were treated with the 
“standard triple protocol” consisting of high-frequency rTMS 
of the left prefrontal cortex (2,000 stimuli, 20  Hz) followed by 
low-frequency rTMS of the bilateral temporo-parietal junction 
areas (total of 2,000 stimuli, 1 Hz). For graphical illustration of 
the study conduct, see Figure 1.
The comparison of participants of both treatment groups 
revealed no differences in the clinical and demographic baseline 
characteristics. Detailed information is provided in Table 2. In 
three patients (all from the individualized group), screening and 
baseline visits were performed at the same visit resulting in only 
one pretreatment assessment. One patient did not provide data 
for visit week 4 (standard treatment). These missing values were 
added by LOCF using data from the screening visit. For the other 
patients, interval between screening and baseline was between 
TaBle 2 | group comparisons of the two treatment arms.
individualized 
rTMs (n = 12)
standard 
rTMs (n = 12)
statistics: 
individualized vs. 
standard rTMs
Gender (female/male) 2/10 2/10 n.a.
Age (years) 57.1 ± 7.4 50.6 ± 12.1 t(22) = 1.582; 
p = 0.128
Mean hearing level 
(dB HL)
25.7 ± 15.9 22.9 ± 13.4 t(22) = 0.476; 
p = 0.639
Tinnitus duration 
(months)
108.2 ± 98.9 154.3 ± 106.8 t(21) = 1.072; 
p = 0.296
Tinnitus laterality 
(right/left/both)
0/2/10 0/2/10 n.a.
TQ (baseline minus 
week 2)
7.2 ± 9.2 3.4 ± 7.0 t(22) = 1.118; 
p = 0.276; d = 0.465
TQ (screening/
baseline minus week 
2/4/12)
8.6 ± 8.9 1.5 ± 8.5 t(22) = 2.002; 
p = 0.058; d = 0.816
NRS loudness 
(baseline minus 
week 2)
0.8 ± 1.9 1.4 ± 2.5 t(22) = 0.649; 
p = 0.289; d = 0.270
NRS loudness 
(screening/baseline 
minus week 2/4/12)
0.9 ± 1.9 1.0 ± 1.5 t(22) = 0.181; 
p = 0.858; d = 0.058
TQ, tinnitus questionnaire (scale: 0–84); NRS, numeric rating scale (scale: 0–10); rTMS, 
repetitive transcranial magnetic stimulation.
FigUre 1 | study structure and patient flow (for detailed information, see Materials and Methods).
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13 and 349 days (or screening and baseline was the same visit) 
with a mean of 81.4 and a SD of 86.03 (median =  53). In the 
individualized treatment group, we had 10 right-handed patients 
and 2 ambidextrous patients; in the standard group, we had 8 
right-handed patients, 2 left-handed patients, and 2 ambidex-
trous patients. A statistical comparison with the Fisher’s exact test 
shows no difference between groups with respect to handedness 
(p =  0.329). In the individualized group, three patients chose 
right frontal and nine left frontal stimulation as a best stimula-
tion site (χ2 = 2.222; df = 2; p = 0.045) and five right temporal 
and seven left temporal stimulation as a best stimulation site 
(p = 0.470), indicating an association of right-handedness with 
left frontal stimulation. However, this association of left frontal 
stimulation with right-handedness is from correlational nature, 
but highlights the need for accounting handedness in rTMS trials.
safety
No severe adverse events occurred during the course of the study. 
One participant withdrew his consent to participate due to the 
experience of headache during the testing session on day 1. This 
patient did not report changes in tinnitus loudness after single 
rTMS sessions and was determined as dropout for the standard 
treatment arm (see Figure  1). A deterioration of tinnitus was 
reported by two patients in the testing session, but did not lead 
to an interruption of the treatment. These patients were treated 
with the standard protocol. Further adverse events included 
headache in two patients (one on 1 day of treatment and one in 
2 days of treatment) of the standard treatment and in one patient 
in the individualized group on 1 treatment day. One patient of the 
standard treatment missed two treatment days due to a common 
cold.
results of the Test session
For the majority of patients, the testing session revealed best 
results for left-sided stimulation for both frontal and temporal 
stimulation resulting in predominant left-hemispheric treat-
ment location in the individualized treatment group (Table 1). 
FigUre 2 | Tinnitus questionnaire total score over the time course of the study (displayed mean ± seM). Repetitive transcranial magnetic stimulation 
treatment took place from baseline until week 2 visit. Week 4 and week 12 assessments represent follow-up.
6
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With respect to tinnitus localization, two patients of both 
treatment groups had purely left-sided tinnitus, and the other 
patients had tinnitus either in both ears or within the head. 
No patient had reported purely right-sided tinnitus (Table 2). 
In the majority of the patients, high-frequency stimulation 
protocols or TBS revealed best results in the testing session 
(Table 1).
efficacy
The mean reduction of tinnitus severity measured by the TQ (57) 
was numerically higher for the individualized treatment group in 
contrast to the standard group (Table 2). Number of responders 
was also higher in the individualized group (Table 1). Graphical 
information on the TQ score at the different assessment time 
points is depicted in Figure 2. Decrease in tinnitus loudness was 
in the same range for the individualized and the standard group 
(Table  2). On a statistical level, individualized treatment (vs. 
standard treatment) showed numerically superior efficacy with 
medium or high effect size on a non-significant level contrast-
ing week 2 and baseline or postvisits and previsits, respectively 
(screening and baseline vs. week 2, 4, and 12) as elicited by the 
TQ. Changes in tinnitus loudness were not significantly different 
between groups with small or negligible effects sizes.
DiscUssiOn
From this pilot study examining the feasibility of an individual-
ized treatment approach in patients suffering from chronic tin-
nitus, three main conclusions can be drawn:
(i) The application of a testing rTMS session with different 
frequencies and stimulation sites has proven to be feasible 
with almost 50% of the patients reporting immediate effects 
in our study sample.
(ii) An individualized treatment approach following this test-
ing session was well tolerated by the majority of patients. 
Adverse events and dropout rates were comparable among 
both study arms and matched prior observations (28).
(iii) The clinical efficacy of an individualized treatment approach 
exceeded the results of a standard treatment approach on 
a descriptive level. Effects for TQ were not significant, but 
showed medium to high effect sizes. Improvement was 
stable for several weeks after the treatment.
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This pilot study addressed the question to what extent clinical 
effects of a single session may serve as predictors for treatment 
response of repeated sessions of rTMS. On a descriptive level, the 
individualized treatment group reported a higher reduction of 
tinnitus severity than the control group treated with a standard 
combined rTMS paradigm.
Our finding that response to a single session may predict 
treatment outcome of prolonged stimulation has similarly been 
detected in the approach to use a single session of rTMS as a 
selection criterion for the implantation of epidural electrodes 
for intractable tinnitus (48, 49). Among patients who responded 
to a single session of TMS, two-third had also long-term benefit 
from epidural stimulation (48). Notably, epidural stimulation 
in chronic tinnitus has been only conducted in few cases of 
intractable tinnitus, and the results should not carelessly be 
transferred to our sample and settings. However, this ratio 
corresponds nicely to our finding that most patients who 
responded to the testing sessions also responded to repeated 
rTMS application.
Our finding that the effect of testing sessions predicts the effect 
of daily treatment is of high clinical relevance as rTMS treatment 
results are characterized by high interindividual variability and 
no demographic or clinical tinnitus baseline characteristics could 
be identified as predictors of rTMS treatment response yet (65). 
The high interindividual variability in rTMS treatment response 
in previous studies has been mainly interpreted as an expres-
sion of the variability of tinnitus pathophysiology (40). If this 
was correct, it would be plausible that different patients might 
respond to different stimulation paradigms, thus profiting from 
individualized “trial-and-error” treatment attempts (65). Even, if 
the individualized treatment showed higher efficacy in contrast 
to standard treatment, the SD of TQ change in the two groups 
was similar for both treatment arms. This indicates a similar 
variability in treatment response and suggests that individualized 
treatment does not increase efficacy by reducing interindividual 
variability.
One discussable issue is the identification of the most efficient 
protocol in the testing session. In each patient, 20 different 
protocols were tested (5 different frequencies at 4 different 
sites). For practical reasons, the intervals between the different 
protocols were rather short. Investigators were instructed to wait 
until the tinnitus returned to baseline level before applying the 
next protocol. Thus, the interval between different protocols was 
typically in the range between 1 and 5 min. A testing session, 
therefore, took approximately 1 h per individual, in some cases 
even longer. However, we are aware that it cannot be excluded 
that the effects of the different protocols were influenced by 
after-effects of the preceding protocols. Thus, the increased 
responsiveness to high frequency and TBS stimulation may have 
been partly due to the accumulation of stimulation effects as 
the order of the different protocols was not randomized during 
the testing session. It could also be the case that it took some 
time for the individuals to acclimate to the testing scenario. 
However, it is unlikely that the effects were only driven by 
accumulation of stimuli or habituation to the testing situation 
as TBS was always applied as the last protocol, but not every 
patient reported best improvement with TBS. Nevertheless, 
future studies investigating individualized TMS should take 
a potential order effect into account and follow a randomized 
protocol regarding the sequence of stimulation frequencies and 
stimulated hemispheres.
A certain dissociation of the effects of a single session and 
repeated sessions was observed. Although patients reported loud-
ness reductions of their tinnitus during the testing session, daily 
treatment had only an effect on tinnitus distress but not on tin-
nitus loudness. Possible reasons might be related to differences in 
the applied scales for tinnitus loudness (percentage change after a 
single session vs. 11 graded numeric rating for tinnitus loudness). 
Furthermore, ratings during a single session were conducted with 
inserted earplugs, whereas clinical evaluation over the course of 
the treatment was done without hearing protection obscuring 
possible changes in tinnitus loudness.
We are well aware that the comparison between the individu-
alized treatment group and the standard treatment group does 
not enable us to disentangle whether the response in the testing 
session serves as a general predictor for response to repeated 
rTMS sessions or whether the individualized protocol was 
relevant for the good outcome in the individualized treatment 
group. In other words, the test session might have only served 
for the identification of responders at the starting point of the 
rTMS treatment period. To further address this issue, future 
studies should be conducted in which patients, who respond to 
TMS testing sessions, are randomized into standard treatment vs. 
individualized treatment.
Notably, the present study was designed as a proof-of-concept 
pilot study, which should primarily evaluate the feasibility and 
tolerability of an individualized rTMS treatment regime in 
chronic tinnitus. Thus, we are well aware about the limiting fac-
tor of the lack of a sham-controlled study group. It cannot be 
excluded that the improved outcome in the individualized group 
was driven by non-specific effects. Patients who experienced tin-
nitus improvement in the testing session might have developed 
higher expectations with respect to the daily treatment, which 
could have contributed to the better outcome. However, active 
control conditions have especially been recommended in rTMS 
studies due to the inherent limitations of sham conditions (36, 
66, 67). For future studies using this individualized approach, 
we would suggest the splitting of the patients reporting changes 
in tinnitus perception into two arms—one arm treated with the 
individualized protocol and one arm treated with a standard 
protocol. An optimal design would also include a third sham 
arm (68).
In summary, our pilot data confirm the potential of individu-
alized rTMS treatment as a non-invasive, safe, and well-tolerated 
method of brain stimulation in the treatment of chronic tinnitus. 
Descriptive analyses indicate a remarkable superior effect of the 
individualized treatment in contrast to standard treatment even 
if the standard treatment with two or three stimulation sites was 
shown to be more effective than single-site stimulations (36, 66, 
67, 69). Individualized rTMS in chronic tinnitus might provide 
a basis for an individualized, “tailored” rTMS-based therapeutic 
approach also in other neuropsychiatric disorders. Combining a 
single session with electroencephalography during the first treat-
ment day (70) might help to identify neuronal markers, which 
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might enable reliable predictions regarding treatment response 
after daily rTMS. This approach could eventually be useful in 
identifying successful TMS protocols based on EEG markers also 
in those patients, who were not able to detect perceptual improve-
ments in the test session.
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